Wednesday, April 22, 2026
29.4 C
Bengaluru

Breaking Performance Barriers

[wpfilebase tag=file id=57 tpl=download-button /]

Inside this Issue

1. LinkedIn Leadership from K. Hariram

“How to lead a team of seniors” and “importance of keeping the ego in check when giving negative feedback” are issues covered in this edition.

2. Patient Access Part-III: Future of eHealthcare – Patient Convenience by Pankaj Mehrotra

Providing patients with an integrated health solution rather than just pills, is the future of pharma.

3. e-Pharmacies Are Here to Stay by Rinkesh Shah

Only a few compliance issues remain which can easily be ironed out. The consumer will benefit from this service.

4. Personalized Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

5. What Barcodes Can Bring to Patient Support Programmes by Amaninder S Dhillon

Barcoding medicine packs can throw up valuable data for pharma companies while enhancing patient compliance.

6. Real World Data: A Primer by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal and Mahendra Kumar Rai

Unlike experimental data, real world data is more robust in terms of predicting outcomes, once inconsistancies are weeded out.

7. To, Every New Frontline Manager by K. Hariram

An open letter to every new Frontline Manager, in verse.

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img